Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Research Initiative To Build Capacity in Black and Hispanic Communities and Among Researchers Who Conduct HIV/AIDS Epidemiologic and Prevention Research in These Communities, Program Announcement Number 03097

---
identifier: "/us/fr/03-19829"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Research Initiative To Build Capacity in Black and Hispanic Communities and Among Researchers Who Conduct HIV/AIDS Epidemiologic and Prevention Research in These Communities, Program Announcement Number 03097"
title_number: 0
title_name: "Federal Register"
section_number: "03-19829"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Research Initiative To Build Capacity in Black and Hispanic Communities and Among Researchers Who Conduct HIV/AIDS Epidemiologic and Prevention Research in These Communities, Program Announcement Number 03097"
positive_law: false
currency: "2003-08-04"
last_updated: "2003-08-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-19829"
document_type: "notice"
publication_date: "2003-08-04"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "68 FR 45825"
fr_volume: 68
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Research Initiative To Build Capacity in Black and Hispanic Communities and Among Researchers Who Conduct HIV/AIDS Epidemiologic and Prevention Research in These Communities, Program Announcement Number 03097

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Research Initiative to Build Capacity in Black and Hispanic Communities and Among Researchers Who Conduct HIV/AIDS Epidemiologic and Prevention Research in these Communities, Program Announcement Number 03097.

*Times and Dates:* 8:30 a.m.-9 a.m., August 18, 2003 (Open). 9 a.m.-5 p.m., August 18, 2003 (Closed). 8:30 a.m.-5 p.m., August 19, 2003 (Closed).

*Place:* The Westin Hotel at Perimeter, 7 Concourse Parkway, Atlanta, GA 30328, Telephone 770.395.3900.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in Section552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement Number 03097.

**Note:**

Due to program oversight, this *Federal Register* Notice is being published less than 15 days before the date of the meeting.

**FOR FURTHER INFORMATION CONTACT:**

Beth Wolfe, Prevention Support Office, National Center for HIV, STD, and TB Prevention, CDC, 1600 Clifton Road, NE., MS-E07, Atlanta, GA 30333, Telephone 404.639.8531.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: July 30, 2003.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).